| __timestamp | Corcept Therapeutics Incorporated | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 241751000 |
| Thursday, January 1, 2015 | 1361000 | 322292000 |
| Friday, January 1, 2016 | 2058000 | 344320000 |
| Sunday, January 1, 2017 | 3554000 | 374644000 |
| Monday, January 1, 2018 | 5215000 | 1820000 |
| Tuesday, January 1, 2019 | 5504000 | 4000000 |
| Wednesday, January 1, 2020 | 5582000 | 12000000 |
| Friday, January 1, 2021 | 5281000 | 11000000 |
| Saturday, January 1, 2022 | 5385000 | 14000000 |
| Sunday, January 1, 2023 | 6481000 | 9133000 |
| Monday, January 1, 2024 | 11215000 |
Unleashing the power of data
In the competitive landscape of biotechnology, cost efficiency is paramount. This analysis compares the cost of revenue efficiency between Corcept Therapeutics Incorporated and Ionis Pharmaceuticals, Inc. over a decade, from 2014 to 2023. Corcept Therapeutics has demonstrated a consistent increase in cost efficiency, with costs rising from approximately $882,000 in 2014 to $6.5 million in 2023. This represents a growth of over 600%, indicating a strategic scaling of operations.
Conversely, Ionis Pharmaceuticals experienced a more volatile trajectory. Starting with a cost of $242 million in 2014, Ionis saw fluctuations, with a significant drop to $1.8 million in 2018, before stabilizing around $9 million in 2023. This variability suggests a dynamic approach to managing operational costs, possibly reflecting shifts in strategic focus or market conditions.
Understanding these trends provides valuable insights into the operational strategies of these biotech giants.
Cost of Revenue: Key Insights for AbbVie Inc. and Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Ionis Pharmaceuticals, Inc. vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored